Search research articles
Contact Us
Filters
Showing results (21-30 of 127) with videos related to
Page
of 13
Sort By:
The Yale Journal of Biology and Medicine
|
January 1, 1988
The pharmacologic basis for the efficacy of high-dose Ara-C and sequential asparaginase in adult acute myelogenous leukemia
R L Capizzi, C White
Medical and Pediatric Oncology
|
January 1, 1982
Sequential high-dose cytosine arabinoside and asparaginase in refractory acute leukemia
R L Capizzi, Y C Cheng
Medical and Pediatric Oncology
|
January 1, 1982
Enzymology of cytosine arabinoside
Y C Cheng, R L Capizzi
Cancer
|
April 15, 1984
Differentiation versus cytoreduction during remission induction in acute nonlymphoblastic leukemia treated with sequential high-dose ara-C and asparaginase
D W Ross, R L Capizzi
Advances in Experimental Medicine and Biology
|
January 1, 1993
General aspects of cancer chemotherapy in the aged
R A Fleming, R L Capizzi
Seminars in Oncology Nursing
|
November 1, 1985
The prevention and treatment of immediate hypersensitivity reactions from cancer chemotherapy
J B Craig, R L Capizzi
Mutation Research
|
January 1, 1973
A table for the estimation of the spontaneous mutation rate of cells in culture
R L Capizzi, J W Jameson
Seminars in Oncology
|
June 1, 1987
Sequential high-dose ara-C and asparaginase versus high-dose ara-C alone in the treatment of patients with relapsed and refractory acute leukemias
R L Capizzi, B L Powell
Cancer Research
|
July 15, 1992
1-beta-D-arabinofuranosylcytosine-diphosphate-choline is formed by the reversal of cholinephosphotransferase and not via cytidylyltransferase
G L Kucera, R L Capizzi
Cancer Research
|
May 15, 1991
A critical role for uridine nucleotides in the regulation of deoxycytidine kinase and the concentration dependence of 1-beta-D-arabinofuranosylcytosine phosphorylation in human leukemia cells
J C White, R L Capizzi
Page
of 13
Search research articles
Search
Showing results (21-30 of 127) with videos related to
Sort By:
Page
of 13
The Yale Journal of Biology and Medicine
|
January 1, 1988
The pharmacologic basis for the efficacy of high-dose Ara-C and sequential asparaginase in adult acute myelogenous leukemia
R L Capizzi, C White
Medical and Pediatric Oncology
|
January 1, 1982
Sequential high-dose cytosine arabinoside and asparaginase in refractory acute leukemia
R L Capizzi, Y C Cheng
Medical and Pediatric Oncology
|
January 1, 1982
Enzymology of cytosine arabinoside
Y C Cheng, R L Capizzi
Cancer
|
April 15, 1984
Differentiation versus cytoreduction during remission induction in acute nonlymphoblastic leukemia treated with sequential high-dose ara-C and asparaginase
D W Ross, R L Capizzi
Advances in Experimental Medicine and Biology
|
January 1, 1993
General aspects of cancer chemotherapy in the aged
R A Fleming, R L Capizzi
Seminars in Oncology Nursing
|
November 1, 1985
The prevention and treatment of immediate hypersensitivity reactions from cancer chemotherapy
J B Craig, R L Capizzi
Mutation Research
|
January 1, 1973
A table for the estimation of the spontaneous mutation rate of cells in culture
R L Capizzi, J W Jameson
Seminars in Oncology
|
June 1, 1987
Sequential high-dose ara-C and asparaginase versus high-dose ara-C alone in the treatment of patients with relapsed and refractory acute leukemias
R L Capizzi, B L Powell
Cancer Research
|
July 15, 1992
1-beta-D-arabinofuranosylcytosine-diphosphate-choline is formed by the reversal of cholinephosphotransferase and not via cytidylyltransferase
G L Kucera, R L Capizzi
Cancer Research
|
May 15, 1991
A critical role for uridine nucleotides in the regulation of deoxycytidine kinase and the concentration dependence of 1-beta-D-arabinofuranosylcytosine phosphorylation in human leukemia cells
J C White, R L Capizzi
Page
of 13